Incretin levels 1 month after laparoscopic single anastomosis gastric bypass surgery in non-morbid obese type 2 diabetes patients

Asian Journal of Surgery

Volumn 37, Issue 3, 2014, Pages 130-137

  Kim, Myung Jin ^a   Park, Hyeong Kyu ^a   Byun, Dong Won ^a   Suh, Kyo Il ^a   Hur, Kyung Yul ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

gastric bypass; incretin; metabolic surgery; type 2 diabetes mellitus

Indexed keywords

INCRETIN;

ADULT; AGED; BLOOD; DIABETES MELLITUS, TYPE 2; FEMALE; HUMAN; LAPAROSCOPY; MALE; MIDDLE AGED; PROCEDURES; STOMACH BYPASS;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; HUMANS; INCRETINS; LAPAROSCOPY; MALE; MIDDLE AGED;

EID: 84903551079     PISSN: 10159584     EISSN: 02193108     Source Type: Journal    
DOI: 10.1016/j.asjsur.2013.09.008     Document Type: Article

References (48)

1. IDF Diabetes Atlas 5th ed. 2011 International Diabetes Federation Brussels http://www.idf.org/diabetesatlas
2. D.P. Guh, W. Zhang, N. Bansback, Z. Amarsi, C.L. Birmingham, and A.H. Anis The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis BMC Public Health 9 2009 88
3. Korea Health Statistics 2010: Korea National Health and Nutrition Examination Survey, the Ministry of Health and Welfare 2010 http://knhanes.cdc. go.kr
4. H. Buchwald, Y. Avidor, and E. Braunwald et al. Bariatric surgery: a systematic review and meta-analysis JAMA 292 2004 1724 1737
5. G. Mingrone, A. DeGaetano, and A.V. Greco et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids Diabetologia 40 1997 599 605
6. W.J. Pories, and R.J. Albrecht Etiology of type 2 diabetes mellitus: role of the foregut World J Surg 25 2001 527 531
7. F. Rubino, and M. Gagner Potential of surgery for curing type 2 diabetes mellitus Ann Surg 236 2002 554 559
8. E.G. Scott, L.G. Frank, and K. Stanley Effects of obesity surgery on non-insulin-dependent diabetes mellitus Arch Surg 137 2002 1109 1117
9. B. Laferrere, J. McGinty, and S. Heshka et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 2007 1709 1716
10. H.U. Roger, and M.E. Anna Entero-insular axis Arch Intern Med 123 1969 261 266
11. W. Creutzfeldt The incretin concept today Diabetologia 16 1979 75 85
12. M.J. Perley, and D.M. Kipnis Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects J Clin Invest 46 1967 1954 1962
13. F. Preitner, M. Ibberson, and I. Franglin et al. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors J Clin Invest 113 2004 635 645
14. J.K. Timothy, and F.H. Joel The glucagon-like peptides Endocr Rev 20 1999 876 913
15. M.G. Fiona, W. Leanne, K.S. Anna, and R. Frank A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line Diabetes 52 2003 1147 1154
16. J.M. Juris, A.N. Michael, E.S. Wolfgang, and G. Baptist Gastric inhibitory polypeptide: the neglected incretin revisited Regul Pept 107 2002 1 13
17. W. Creutzfeldt The entero-insular axis in type 2 diabetes - incretins as therapeutic agents Exp Clin Endocrinol Diabetes 109 suppl 2 2001 S288 S303
18. R. Fetner, J. McGinty, C. Russell, X.P. Sunyer, and B. Laferrere Incretins, diabetes, and bariatric surgery: a review Surg Obes Relat Dis 1 2005 589 598
19. 2 J Gastrointest Surg 12 2008 945 952
20. M. Garcia-Caballero, M. Valle, and J.M. Martinez-Moreno et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with one anastomosis gastric bypass Nutr Hosp 27 2012 623 631
21. E. Shafrir Development and consequences of insulin resistance: lessons from animals with hyperinsulinemia Diabete Metab 22 1997 131 148
22. B. Detournay, S. Cross, and B. Charbonnel et al. Managing type 2 diabetes in France: the ECODIA survey Diabete Metab 26 2000 363 369
23. F. Rubino, M. Gagner, and P. Gentileschi et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism Ann Surg 240 2004 236 242
24. N. Scopinaro, G. Marinari, and G.B. Camerini et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study Diabetes Care 28 2005 2406 2411
25. T. Tejirian, C. Jensen, and E. Dutson Bariatric surgery and type 2 diabetes mellitus: surgically induced remission J Diab Sci Technol 2 2008 685 691
26. R. Fetner, F.X. Pi-Sunyer, C.D. Russell, and B. Laferrère Incretins, diabetes and bariatric surgery: a review Term Med 6 2005 589 597
27. J.E. Varela Bariatric surgery: a cure for diabetes? Curr Opin Clin Nutr Metab Care 14 2011 396 401
28. 2 Obes Surg 29 2011 1344 1349
29. F. Rubino, S.L. R'bibo, F. del Genio, M. Mazumdar, and T.E. McGraw Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus Nat Rev Endocrinol 6 2010 102 109
30. F. Rubino, A. Forgione, and D.E. Cummings et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes Ann Surg 244 2006 741 749
31. S. Santoro, L.C. Castro, and M.C. Velhote et al. Sleeve gastrectomy with transit bipartition. A potent intervention for metabolic syndrome and obesity Ann Surg 256 2012 104 110
32. T. Vilsboll, T. Krarup, and J. Sonne et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus J Clin Endocrinol Metab 88 2003 2706 2713
33. T. Vilsboll, T. Krarup, and C.F. Deacon et al. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients Diabetes 50 2001 609 613
34. L.L. Baggio, and D.J. Drucker Biology of incretins: GLP-1 and GIP Gastroenterology 132 2007 2131 2157
35. Y.M. Cho, C.E. Merchant, and T.J. Kieffer Targeting the glucagon receptor family for diabetes and obesity therapy Pharmacol Ther 135 2012 247 278
36. F.K. Knob, T. Vilsboll, S. Madsbad, J.J. Holst, and T. Krarup Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus Diabetologia 50 2007 797 805
37. S. Dinneen, A. Alzaid, D. Turk, and R. Rizza Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM Diabetologia 38 1995 337 343
38. P. Shah, A. Vella, A. Basu, R. Basu, W.F. Schwenk, and R.A. Rizza Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus J Clin Endocrinol Metab 85 2000 4053 4059
39. N. Mentis, I. Vardarli, and L.D. Kothe et al. GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes Diabetes 60 2011 1270 1276
40. G. Mingrone Role of the incretin system in the remission of type 2 diabetes following bariatric surgery Nutr Metab Cardiovasc Dis 18 2008 574 579
41. Y.G. Kim, S. Hahn, T.J. Oh, S.H. Kwak, K.S. Park, and Y.M. Cho Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis Diabetologia 56 2013 696 708
42. C.L. Chang, J.J. Cai, C. Lo, J. Amigo, J.I. Park, and S.Y. Hsu Adaptive selection of an incretin gene in Eurasian populations Genome Res 21 2011 21 32
43. Y.H. Kao, C.H. Lo, and C.K. Huang Relationship of bypassed limb length and remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass Surg Obes Relat Dis 8 6 2012 Nov-Dec e82 e84 http://dx.doi.org/10.1016/j.soard.2011. 10.011. [Epub 2011 Oct 30]
44. G. Mingrone, and L. Castagneto-Gissey Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery Diabete Metab 35 2009 518 523
45. 2: an integrative review of early studies Obes Surg 20 2010 776 790
46. 2 Obes Surg 21 2011 889 895
47. R. Rutledge The mini-gastric bypass: experience with the first 1274 cases Obes Surg 11 2011 276 280
48. M.C. Bunck, A. Corner, and B. Eliasson et al. Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes Diabetes Care 34 2011 2041 2047